Physician profile
Gary Dicanio
NPI 1770665721
$15,474.28
in general payments reported to CMS, 2019-2025
61 companies · $1,970 in 2025
The $1,970 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,088 · 2020: $2,083 · 2021: $2,545 · 2022: $2,079 · 2023: $2,236 · 2024: $1,473 · 2025: $1,970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,679.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,948.35 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $1,548.83 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $1,120.30 | 2019-2025 | |
| Lilly USA, LLC | $995.94 | 2019-2025 | Jardiance, Zepbound, Emgality |
| Novo Nordisk INC | $778.62 | 2019-2025 | Ozempic, Rybelsus |
| Horizon Therapeutics Plc | $669.56 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $622.10 | 2019-2025 | Airsupra, Farxiga |
| Axsome Therapeutics, INC. | $550.72 | 2023-2025 | Sunosi |
| Indivior INC. | $542.26 | 2019-2024 | Sublocade |
| Exact Sciences Corporation | $498.58 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $461.40 | 2019-2023 | Belsomra, Steglatro |
| Daiichi Sankyo INC. | $458.31 | 2019-2023 | Injectafer |
| Scilex Pharmaceuticals INC. | $447.71 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $359.03 | 2019-2023 | Belbuca |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.95 | 2019-2022 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Dicanio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.